The relationship between prostate‐specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate‐specific antigen levels

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|10|1034-1042

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.10, 2015-07, pp. : 1034-1042

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate-Specific Antigen Levels and Prognosis in Patients with Hormone-Refractory Prostate Cancer Treated with Low-Dose Dexamethasone

By  

Urologia Internationalis, Vol. 68, Iss. 1, 2002-01 ,pp. : 10-15

Karger

Access to resources Recommend Favorite

The prostate-specific antigen test

By Roobol Monique J  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 5, 2013-09 ,pp. : 423-426

Informa Healthcare

Access to resources Recommend Favorite

Prostate Cancer Screening with Prostate-Specific Antigen in Hemodialysis Patients

By  

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 334-337

Karger

Access to resources Recommend Favorite

Patients with Low Prostate-Specific Antigen Levels (≤4 ng/ml) Would Benefit from a Twelve-Core Biopsy Protocol for Prostate Cancer Detection

By  

Urologia Internationalis, Vol. 78, Iss. 4, 2007-05 ,pp. : 318-322

Karger

Access to resources Recommend Favorite

The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate‐specific antigen and biopsy outcome

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 3007-3011

John Wiley & Sons Inc

Access to resources Recommend Favorite